BillionToOne, Inc.

NasdaqGS:BLLN Stock Report

Market Cap: US$4.6b

BillionToOne Past Earnings Performance

Past criteria checks 2/6

There is insufficient data on BillionToOne's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare Industry Growth8.50%
Revenue growth rate100.30%
Return on equity5.82%
Net Margin7.02%
Last Earnings Update31 Mar 2026

Recent past performance updates

Analysis Article May 13

BillionToOne's (NASDAQ:BLLN) Earnings May Just Be The Starting Point

BillionToOne, Inc.'s ( NASDAQ:BLLN ) strong earnings report was rewarded with a positive stock price move. We have done...

Recent updates

Seeking Alpha May 20

BillionToOne - Starting 2026 Strong

Summary BillionToOne delivered 84% YoY Q1 sales growth, driven by prenatal and oncology clinical testing segments. BillionToOne raised full-year revenue guidance to $450–$465 million, reflecting strong demand, pricing, and volume momentum. GAAP operating profit reached $17.8 million, demonstrating operating leverage and margin expansion amid declining pricing pressure. New product launches like Unity Confirm and oncology diversification reinforce BillionToOne's platform superiority and support a positive growth outlook. Read the full article on Seeking Alpha
Analysis Article May 13

BillionToOne's (NASDAQ:BLLN) Earnings May Just Be The Starting Point

BillionToOne, Inc.'s ( NASDAQ:BLLN ) strong earnings report was rewarded with a positive stock price move. We have done...

Revenue & Expenses Breakdown

How BillionToOne makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:BLLN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 263552516054
31 Dec 25305314349
30 Sep 25254-1112546
30 Jun 25209-2711343
31 Mar 25177-3810039
31 Dec 24153-429137
31 Dec 2372-836422

Quality Earnings: BLLN has a large one-off loss of $9.7M impacting its last 12 months of financial results to 31st March, 2026.

Growing Profit Margin: BLLN became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BLLN has become profitable over the past 5 years.

Accelerating Growth: BLLN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: BLLN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (17%).


Return on Equity

High ROE: BLLN's Return on Equity (5.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/18 22:11
End of Day Share Price 2026/06/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BillionToOne, Inc. is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
Subhalaxmi NambiGuggenheim Securities, LLC
Tycho PetersonJefferies LLC